{
  "id": "5a70d43b99e2c3af26000003",
  "type": "yesno",
  "question": "Does prolactinoma increase osteoporosis risk?",
  "ideal_answer": "Yes, prolactinomas increase risk of osteoporosis. Prolactinomas also cause hypogonadism, infertility, and tumor mass effects.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/26319389",
    "http://www.ncbi.nlm.nih.gov/pubmed/22553947",
    "http://www.ncbi.nlm.nih.gov/pubmed/27446618",
    "http://www.ncbi.nlm.nih.gov/pubmed/20205855",
    "http://www.ncbi.nlm.nih.gov/pubmed/26243714",
    "http://www.ncbi.nlm.nih.gov/pubmed/17578827",
    "http://www.ncbi.nlm.nih.gov/pubmed/25472533",
    "http://www.ncbi.nlm.nih.gov/pubmed/23965473",
    "http://www.ncbi.nlm.nih.gov/pubmed/21479837",
    "http://www.ncbi.nlm.nih.gov/pubmed/11293923",
    "http://www.ncbi.nlm.nih.gov/pubmed/15816365",
    "http://www.ncbi.nlm.nih.gov/pubmed/9550540"
  ],
  "snippets": [
    {
      "text": "Prolactinoma: A Massive Effect on Bone Mineral Density in a Young Patient.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27446618",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Osteoporosis has been noted to be an issue in postmenopausal women with prolactinomas. This case shows a similar impact on bone health in a young male resulting in low bone mineral density for age based on Z-score. This case report highlights the possible mechanisms for the bone loss in the setting of prolactinoma and the need for assessing bone health in such patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27446618",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Hyperprolactinaemia related to prolactinoma significantly (more than functional hyperprolactiaemia) increases the risk of osteopenia, osteoporosis and bone fractures. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26319389",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Prolactinomas are the most common type of functional pituitary tumor. Effective hyperprolactinemia treatment is of great importance, due to its potential deleterious effects including infertility, gonadal dysfunction and osteoporosis. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26243714",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Prolactinomas cause hypogonadism, infertility, osteoporosis, and tumor mass effects, and are the most common type of neuroendocrine tumor.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25472533",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We present a 22-year-old man with multiple osteoporotic fractures associated with prolactinoma despite the use of teriparatide for 18 months. We emphasize and highlight the importance of hyperprolactinemia and fractures caused by high prolactin levels.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23965473",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: Patients with prolactinoma seem to be at high risk for osteopenia. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22553947",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "RESULTS: Compared to the matched controls, BMD of patients with prolactinoma or craniopharyngioma significantly decreased. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22553947",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSION: In the premenopausal women, patients with prolactinoma or craniopharyngioma are often accompanied with osteopenia or osteoporosis, and disease duration and hypogonadism are the risk factors of bone loss in prolactinoma.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22553947",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Data on osteoporotic fractures in hyperprolactinemia are limited. An increased prevalence of radiological vertebral fractures was recently observed in women with prolactin (PRL)-secreting adenoma, whereas it is unknown whether this observation may reflect a more general increased risk of fractures in this disease and whether the prevalence of fractures in males is affected by gonadal status.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21479837",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Prolactinoma presenting as chronic anaemia with osteoporosis: a case report.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20205855",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Six years later, he was evaluated and diagnosed with a prolactinoma and resultant osteoporosis. Prolactinoma in old people may present insidiously with chronic anaemia and osteoporosis with or without sexual dysfunction.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20205855",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The relative risk for developing osteoporosis in women with prolactinoma was found to be 4.5, indicating that hyperprolactinemia in women is a major risk factor for osteoporosis.<br>",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11293923",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "<b>INTRODUCTION</b>: Osteopenia and osteoporosis because of hyperprolactinaemia caused by prolactinoma may be followed by an increased risk of fracture.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17578827",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Univariate and multivariate regression analysis indicated that the bone loss in prolactinomas was significantly correlated to disease duration and hypogonadism.<br><b>CONCLUSION</b>: In the premenopausal women, patients with prolactinoma or craniopharyngioma are often accompanied with osteopenia or osteoporosis, and disease duration and hypogonadism are the risk factors of bone loss in prolactinoma.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22553947",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "High serum prolactin levels lead to increase of the risk of osteopenia or/and osteoporosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26319389",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Prolactinoma in old people may present insidiously with chronic anaemia and osteoporosis with or without sexual dysfunction.<br><b>CASE PRESENTATION</b>: We describe the case of a 70-year-old Caucasian man who presented with mild anaemia and tiredness.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20205855",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In the premenopausal women, patients with prolactinoma or craniopharyngioma are often accompanied with osteopenia or osteoporosis, and disease duration and hypogonadism are the risk factors of bone loss in prolactinoma.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22553947",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The relative risk for developing osteoporosis in women with prolactinoma was found to be 4.5, indicating that hyperprolactinemia in women is a major risk factor for osteoporosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11293923",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSION In the premenopausal women, patients with prolactinoma or craniopharyngioma are often accompanied with osteopenia or osteoporosis, and disease duration and hypogonadism are the risk factors of bone loss in prolactinoma.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22553947",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Prolactinoma in old people may present insidiously with chronic anaemia and osteoporosis with or without sexual dysfunction.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20205855",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Hyperprolactinaemia related to prolactinoma significantly (more than functional hyperprolactiaemia) increases the risk of osteopenia, osteoporosis and bone fractures.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26319389",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION Osteopenia and osteoporosis because of hyperprolactinaemia caused by prolactinoma may be followed by an increased risk of fracture.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17578827",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In conclusion, men with prolactinoma have high prevalence of osteopenia and osteoporosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15816365",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Humans with prolactinoma are at risk for osteoporosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9550540",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Osteopenia and osteoporosis because of hyperprolactinaemia caused by prolactinoma may be followed by an increased risk of fracture.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17578827",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The relative risk for developing osteoporosis in women with prolactinoma was found to be 4.5, indicating that hyperprolactinemia in women is a major risk factor for osteoporosis..",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11293923",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In the premenopausal women, patients with prolactinoma or craniopharyngioma are often accompanied with osteopenia or osteoporosis, and disease duration and hypogonadism are the risk factors of bone loss in prolactinoma.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22553947",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "https://meshb.nlm.nih.gov/record/ui?ui=D015175",
    "http://www.disease-ontology.org/api/metadata/DOID:5394",
    "https://meshb.nlm.nih.gov/record/ui?ui=D010024",
    "https://meshb.nlm.nih.gov/record/ui?ui=D012306"
  ],
  "exact_answer": "Yes"
}